Funding This study was supported by a Commercial Development & Industry Partnership (CDIP) grant (CT20584-University of Sydney and Whiteley Corporation) and a Department of Industry, Innovation and Science (Innovative Manufacturing CRC Ltd.) and Whiteley Corporation co-funded project grant A Novel Approach to Biofilm Disruption and Removal (IMCRC/WLY/08052019.1)
The decision to stop Zepbound should be made collaboratively, weighing the benefits of continued treatment against patient preferences, side effects, cost considerations, and overall health goals
We aimed to review and harmonize the data available on potential DDIs between GLP1RAs and oral medications
I go in to pummel him just messing around while he's holding a golf club, and you just feel, you're like, Oh, my gosh
That slow ramp shapes what you'll feel: Weeks 1 to 4: starting low This is an adjustment phase